Combining Ibrutinib with immune checkpoint blockade to induce therapeutic antitumor immune response in solid tumors

被引:0
|
作者
Sagiv-Barfi, Idit [1 ]
Kohrt, Holbrook [1 ]
Czerwinski, Debra [1 ]
Ng, Patrick [2 ]
Chang, Betty [2 ]
Levy, Ronald [1 ]
机构
[1] Stanford Univ, Stanford, CA 94305 USA
[2] Pharmacyclics, Sunnyvale, CA USA
关键词
D O I
10.1158/1538-7445.AM2015-251
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
251
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Destabilizing the genome as a therapeutic strategy to enhance response to immune checkpoint blockade: a systematic review of clinical trials evidence from solid and hematological tumors
    Alotaibi, Faizah
    Alshammari, Kanaan
    Alotaibi, Badi A.
    Alsaab, Hashem
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 14
  • [32] Dissecting Response and Resistance to Immune Checkpoint Blockade
    Liu, David
    [J]. ONCOLOGIST, 2018, 23 : S4 - S4
  • [33] Genomic correlates of response to immune checkpoint blockade
    Keenan, Tanya E.
    Burke, Kelly P.
    Van Allen, Eliezer M.
    [J]. NATURE MEDICINE, 2019, 25 (03) : 389 - 402
  • [34] The role of neoantigens in response to immune checkpoint blockade
    Riaz, Nadeem
    Morris, Luc
    Havel, Jonathan J.
    Makarov, Vladimir
    Desrichard, Alexis
    Chan, Timothy A.
    [J]. INTERNATIONAL IMMUNOLOGY, 2016, 28 (08) : 411 - 419
  • [35] Genomic correlates of response to immune checkpoint blockade
    Tanya E. Keenan
    Kelly P. Burke
    Eliezer M. Van Allen
    [J]. Nature Medicine, 2019, 25 : 389 - 402
  • [36] The Puzzle of Predicting Response to Immune Checkpoint Blockade
    Onyshchenko, Mykola
    [J]. EBIOMEDICINE, 2018, 33 : 18 - 19
  • [37] Studying the Antitumor Effect of LGG plus Immune Checkpoint Blockade
    Lichert, Frank
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (06):
  • [38] DNA repair and immune checkpoint blockade response
    Guo, Jimmy A.
    Alshalalfa, Mohammed
    Kim, Daniel Y.
    Hoffman, Hannah I.
    Shiau, Carina
    Su, Jennifer
    Hwang, William L.
    Mahal, Brandon A.
    [J]. CANCER GENETICS, 2022, 264 : 1 - 4
  • [39] Harnessing immune responses in prostate MMRd tumors treated with immune checkpoint blockade
    Badia, Marcel Arias
    Fan, Zenghua
    Lwin, Yee May
    Chen, Peixi
    Srinath, Aahir
    Fong, Lawrence
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [40] Combining toll-like receptor agonists with immune checkpoint blockade affects antitumor vaccine efficacy
    Jeon, Donghwan
    Hill, Ethan
    Moseman, Jena E.
    McNeel, Douglas G.
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (05)